Abstract
In this issue of Blood, Grob et al(1) integrate mutational analysis with clinical outcomes and propose merging TP53-mutated myelodysplastic syndrome w......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
